Crinetics Pharmaceuticals, Inc.
Pharmaceutical Preparations · SAN DIEGO
High confidence (85%)
Updated Oct 20, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
Latest material event: Crinetics Pharmaceuticals, Inc. deregistered its securities (Sep 11, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Crinetics Pharmaceuticals, Inc. deregistered its securities
Sep 11, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 ef20081593_1512g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission File Number: 001-38583   Crinetics Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)   6055 Lusk Boulevard, San Diego, California 92121; (858) 450-6464 (Address, including zip code, and telephone numbe…”
Crinetics Pharmaceuticals, Inc. received a delisting notice from its exchange
Sep 1, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The disclosures set forth in the Introductory Note of this Current Report on Form 8-K are incorporated herein by reference. In connection with the consummation of the Merger, the Company requested that the Nasdaq Stock Market LLC ( Nasdaq ) suspend trading in the Company Common Stock effective prior to the opening of trading on the Closing Date. On the Closing Date, following the Effective Time, the Company notified Nasdaq that the Merger had been consummated and requested that Nasdaq…”
Crinetics Pharmaceuticals, Inc. was delisted from its exchange
Sep 1, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001658247 Crinetics Pharmaceuticals, Inc. 001-38583 10222 Barnes Canyon Road Bldg. #2 San Diego CA CALIFORNIA 92121 858-703-6540 Common Stock 17 CFR 240.12d2-2(a)(3) Katelin Rowe CDO Analyst 2026-09-01”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker CRNX on Nasdaq.
- SEC CIK
- 0001658247
- Website
- —
- —
- Headquarters
- SAN DIEGO
- Also known as
- —
- Legal entities
- Crinetics Pharmaceuticals, Inc.
Sources
Every material source used to build this profile.
SEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 ef20081593_1512g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 15   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission File Number: 001-38583   Crinetics Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)   6055 Lusk Boulevard, San Diego, California 92121; (858) 450-6464 (Address, including zip code, and telephone numbe…
View source recordSEC Company Submissions (TIER 1 · UNVERIFIED)
Crinetics Pharmaceuticals, Inc. — Pharmaceutical Preparations (SIC 2834) — SAN DIEGO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001658247 Crinetics Pharmaceuticals, Inc. 001-38583 10222 Barnes Canyon Road Bldg. #2 San Diego CA CALIFORNIA 92121 858-703-6540 Common Stock 17 CFR 240.12d2-2(a)(3) Katelin Rowe CDO Analyst 2026-09-01
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The disclosures set forth in the Introductory Note of this Current Report on Form 8-K are incorporated herein by reference. In connection with the consummation of the Merger, the Company requested that the Nasdaq Stock Market LLC ( Nasdaq ) suspend trading in the Company Common Stock effective prior to the opening of trading on the Closing Date. On the Closing Date, following the Effective Time, the Company notified Nasdaq that the Merger had been consummated and requested that Nasdaq…
View source record
Status history
Every derived status, with the rule that produced it.
- NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 20, 2026, 12:14 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:31 AM
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 02:39 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.